Anti-cancer compounds
US9878984B2 · kind B2 · utility
0Cited by
5References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 8, 2014 |
| Grant date | Jan 30, 2018 |
| Priority date | — |
| Expiry date | Sep 15, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2300/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to anti-cancer compounds, methods for their discovery, and their therapeutic use. In particular, the present invention provides analogs of the known anti-cancer compound amonafide, and structurally and functionally related compounds, and methods of using such compounds as therapeutic agents to treat a number of conditions associated with hyperproliferation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.